Hemophilia Drug Development (HDD 2019)

  • 20-22 August 2019
  • Wyndham Boston Beacon Hill, MA, United States

Hemophilia Drug Development (HDD 2019) is a conference dedicated to the most pressing challenges in the broad spectrum of novel therapies in the treatment of hemophilia.

Hemophilia Drug Development (HDD 2019) covers topics such as:

  • Mechanisms in next generation therapies to understand the biological impacts
  • Optimizing patient-centric approaches to ensure patient engagement
  • How to define endpoints in the era of new drugs
  • The factors that influence patients to adopt novel therapies

Hemophilia Drug Development (HDD 2019) will be held in Boston, MA, United States on 20-22 August 2019.

Venue

Wyndham Boston Beacon Hill
5 Blossom Street,
Boston,
Massachusetts,
United States
  View all Hotels near Venue
Booking.com
1499-3697 US Dollar
No exhibition
Hanson Wade
Rentalcars Savings

Past and Future Events

  • Hemophilia Drug Development (HDD 2020) - Aug 2020, Boston, United States (84616)
  • Hemophilia Drug Development (HDD 2019) - 20-22 Aug 2019, Boston, United States (84615)
  • Hemophilia Drug Development (HDD 2018) - 14-16 Aug 2018, Boston, United States (75995)

Important

Please, check the official conference website for possible changes, before you make any traveling arrangements

Prices are for evaluation only.

Other Events with Similar Categories